The world’s organiser of patient intelligence by medicine
The smart way to understand patient experience
Cutting Edge Access to Patient Experience through AI.
Talking Medicines is a data tech company capturing, curating and structuring the global voice of the patient on launched medicines. Cutting edge data service PatientMetRx uses a combination of AI, ML and NLP to capture and analyse patient experience by medicine. Through mapping the patient voice to regulated medicine information, the company is able to build data points to deliver intelligence on usage across medicines driven by patient data. This intelligence meets compliance for the sector and enables marketing in big pharma to measure patient confidence in their medicines & action the levers for share growth.
Talk to us about
Our Team
Jo Halliday
Founder, CEO
Dr Elizabeth Fairley
Founder, COO
Dr Scott Crae MRCVS
Founder, Business Dev Director
Al Sisto
Chairman
Ben Cons
NXD
Ross Hutcheson
Marketing Manager
Roma English Owen
Data Analyst
Vanja Popovic
Product Engineer
Gary Carson
Consultant Pharmacist
Rob Mackean
Finance Consultant
Julie Regamey
Project Manager
Ellie Halliday
Compliance and Legal
Stewart McKee
Full Stack Developer
Olivia Lane
Sales & Marketing Intern
Toby Corner
Biocurator
Tatiana Nantes
Tom Lynch
Adrian Mursec
Frontend Developer
Soldo Moonshot Award
Winner
Applied AI 2.0 Award
Winner
What is PatientMetRx
Blog
PatientMetRx a new AI driven social intelligence service launches today
Talking Medicines is the world’s first social intelligence company designed specifically for the pharmaceutical industry: PatientMetrx By structuring and translating the patient’s voice on social media into actionable intelligence, it focuses on assisting...
How the pandemic is impacting the way drugs are launched
Though we don’t yet know to what extent, it is clear the pandemic has had and will continue to have an impact on the pharmaceutical industry and how new drugs are launched. From a pharma perspective, not being able to communicate with healthcare professionals in their...
Softening of public attitude towards COVID-19 vaccines
In December Talking Medicines carried out two ‘pulse’ surveys of the UK public to gauge opinion towards COVID-19 vaccines and found that over the month, attitude had softened, with more people intending to take the vaccine once it becomes available to them. The...
Proud to be affiliated with:
